Michael Mendelsohn
CIK 1591109 · last filed 2025-06-17
Michael Mendelsohn is a corporate insider who has filed 12 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for FHTX, was dated Jun 17, 2025. Current disclosed insider exposure totals $7.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$7.9K
4
12
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FHTX | Director | — | $4.18 | — | $0 | 5 | 2025-06-17 |
| CYCN | Director | 2,421 | $3.25 | $7.9K | $0 | 5 | 2022-06-16 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | Director | — | — | — | $0 | 1 | 2015-01-05 |
| Tobira Therapeutics, Inc. (RGDO) Delisted | Director | — | — | — | $0 | 1 | 2014-01-03 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-17 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2024-06-28 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2023-06-22 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2022-06-22 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2022-06-16 | CYCN | Grant (A) | — | $0 | EDGAR |
| 2021-07-14 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2021-06-28 | CYCN | Grant (A) | — | $0 | EDGAR |
| 2020-06-18 | CYCN | Grant (A) | — | $0 | EDGAR |
| 2019-06-04 | CYCN | Grant (A) | — | $0 | EDGAR |
| 2019-04-03 | CYCN | Grant (A) | +2,421 | $0 | EDGAR |